Pancreatic Cancer Research

ResearcherThe University of Texas at AustinNo recent work listed

Livia Schiavinato Eberlin

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-3885-3215; OpenAlex author ID A5038494195; NIH RePORTER profile ID 12053792. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
1
Labs led
2
Collaborators
7
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper, 1 grant

Papers 2

  1. Rapid diagnosis and tumor margin assessment during pancreatic cancer surgery with the MasSpec Pen technology. Last author DOI 10.1073/pnas.2104411118↗
  2. Pancreatic Cancer Surgical Resection Margins: Molecular Assessment by Mass Spectrometry Imaging. Co-author DOI 10.1371/journal.pmed.1002108↗

Grants 1

  1. Advanced Development of the MasSpec Pen for Cancer Diagnosis and Surgical Margin Evaluation R33CA229068↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. William E. Fisher · 1 shared paper, 2021 · strength 0.10
  2. Marta Sans · 1 shared paper, 2021 · strength 0.10
  3. Mary E. King · 1 shared paper, 2021 · strength 0.10
  4. George Van Buren · 1 shared paper, 2021 · strength 0.10
  5. George A. Poultsides · 1 shared paper, 2016 · strength 0.06
  6. Jeffrey Allen Norton · 1 shared paper, 2016 · strength 0.06
  7. Teri A. Longacre · 1 shared paper, 2016 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.